A CLINICAL STUDY ON BING GAN LING ORAL LIQUID FOR TREATMENT OF HEPATITIS C

被引：2

作者：

尤松鑫

周珉

薛博瑜

方泰惠

姜惟

李春婷

许惠琴

姜金祥

汪亿

徐实坪

机构：

[1] Jiangsu Provincial TCM Hospital

[2] Nanjing First Hospital Jiangdongmen Branch

[3] Nanjing University of Traditional Chinese Medicine and Pharmacy and Materia Medico Nanjing 210029

来源：

JournalofTraditionalChineseMedicine | 1998年 / 03期

关键词：

HCV; RNA; A CLINICAL STUDY ON BING GAN LING ORAL LIQUID FOR TREATMENT OF HEPATITIS C; oral; BGL;

D O I：

10.19852/j.cnki.jtcm.1998.03.014

中图分类号：

R259.1 [];

学科分类号：

100506 ;

摘要：

Based on the principles of cooling the blood to expel the pathogenic toxins and regulating the function of liver and activating the spleen in traditional Chinese medicine, 60 cases of chronic hepatitis C were treated with Bing Gan Ling (BGL), an oral liquid, which is composed mainly of Shuiniujiao (Cornu Bubali), Huzhang (Rhizoma Polygoni Cuspidati), Chishao (Radix Paeoniae Rubra), and Huangqi (Radix Astragali), etc. The total effective rate was 86.7%, which is considerably better than that of the control group (P< 0.01). The animal experiments and pathological studies suggest that the above-mentioned prescription has marked action of protecting the liver and lowering the activity of enzymes; and that it can ameliorate the acute liver injury induced by D-galactosamine.

引用

页码：209 / 214

页数：6